These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38751633)

  • 1. Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine A
    Claff T; Mahardhika AB; Vaaßen VJ; Schlegel JG; Vielmuth C; Weiße RH; Sträter N; Müller CE
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1415-1425. PubMed ID: 38751633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor.
    Lane JR; Klein Herenbrink C; van Westen GJ; Spoorendonk JA; Hoffmann C; IJzerman AP
    Mol Pharmacol; 2012 Mar; 81(3):475-87. PubMed ID: 22188926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
    Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
    Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of adenosine A
    Claff T; Schlegel JG; Voss JH; Vaaßen VJ; Weiße RH; Cheng RKY; Markovic-Mueller S; Bucher D; Sträter N; Müller CE
    Commun Chem; 2023 Jun; 6(1):106. PubMed ID: 37264098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.
    Bruzzese A; Dalton JAR; Giraldo J
    PLoS Comput Biol; 2020 Apr; 16(4):e1007818. PubMed ID: 32298258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Mutations of the Adenosine A
    Feng C; Wang X; Jespers W; Liu R; Zamarbide Losada SD; Gorostiola González M; van Westen GJP; Danen EHJ; Heitman LH
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Na
    Noël F; do Monte FM
    J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A
    Shiriaeva A; Park D; Kim G; Lee Y; Hou X; Jarhad DB; Kim G; Yu J; Hyun YE; Kim W; Gao ZG; Jacobson KA; Han GW; Stevens RC; Jeong LS; Choi S; Cherezov V
    J Med Chem; 2022 Sep; 65(17):11648-11657. PubMed ID: 35977382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
    Pang X; Yang M; Han K
    Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A
    Jacobson KA; Suresh RR; Oliva P
    Int Rev Neurobiol; 2023; 170():1-27. PubMed ID: 37741687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A
    Eddy MT; Martin BT; Wüthrich K
    Structure; 2021 Feb; 29(2):170-176.e3. PubMed ID: 33238145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a constitutive active mutant of adenosine A
    Cui M; Zhou Q; Xu Y; Weng Y; Yao D; Zhao S; Song G
    IUCrJ; 2022 May; 9(Pt 3):333-341. PubMed ID: 35546802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular cysteine residues in the adenosine A2A receptor.
    De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
    Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-millisecond conformational dynamics of the A
    Maslov I; Volkov O; Khorn P; Orekhov P; Gusach A; Kuzmichev P; Gerasimov A; Luginina A; Coucke Q; Bogorodskiy A; Gordeliy V; Wanninger S; Barth A; Mishin A; Hofkens J; Cherezov V; Gensch T; Hendrix J; Borshchevskiy V
    Commun Biol; 2023 Apr; 6(1):362. PubMed ID: 37012383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures.
    Madsen JJ; Ye L; Frimurer TM; Olsen OH
    Protein Sci; 2022 Nov; 31(11):e4456. PubMed ID: 36134696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global insights into the fine tuning of human A
    Ferré G; Anazia K; Silva LO; Thakur N; Ray AP; Eddy MT
    Cell Rep; 2022 Dec; 41(12):111844. PubMed ID: 36543140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of adenosine A
    Mizumura T; Kondo K; Kurita M; Kofuku Y; Natsume M; Imai S; Shiraishi Y; Ueda T; Shimada I
    Sci Adv; 2020 Mar; 6(12):eaay8544. PubMed ID: 32206717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.